These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8676904)

  • 1. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.
    Ashby J; Waters MD; Preston J; Adler ID; Douglas GR; Fielder R; Shelby MD; Anderson D; Sofuni T; Gopalan HN; Becking G; Sonich-Mullin C
    Mutat Res; 1996 Jun; 352(1-2):153-7. PubMed ID: 8676904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis.
    Sonich-Mullin C; Fielder R; Wiltse J; Baetcke K; Dempsey J; Fenner-Crisp P; Grant D; Hartley M; Knaap A; Kroese D; Mangelsdorf I; Meek E; Rice JM; Younes M;
    Regul Toxicol Pharmacol; 2001 Oct; 34(2):146-52. PubMed ID: 11603957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
    Silva Lima B; Van der Laan JW
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):135-43. PubMed ID: 11067770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of formalizing a quantitative evaluation of the genetic danger of chemical compounds for man].
    Tarasov VA; Aslanian MM; Abilev SK
    Genetika; 1999 Nov; 35(11):1585-99. PubMed ID: 10624578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International harmonization for the risk assessment of pesticides: results of an IPCS survey.
    Dragula C; Burin G
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):337-53. PubMed ID: 7724837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interpretation and analysis of cytogenetic data.
    Danford N
    Methods Mol Biol; 2012; 817():93-120. PubMed ID: 22147570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the induction of chromosomal aberrations and gene mutations in rodent germ cells.
    Adler ID; Carere A; Eichenlaub-Ritter U; Pacchierotti F
    Environ Res; 2007 May; 104(1):37-45. PubMed ID: 17052706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The hygienic evaluation of the mutagenic potential of industrial wastes].
    Zhurkov VS; Rusakov NV; Tonkopiĭ NI; Sycheva LP; Akhal'tseva LV; Neiaskina EV; Pirtakhiia NV; Malysheva AG; Rastiannikov EG
    Gig Sanit; 1998; (4):30-2. PubMed ID: 9721500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.